A carregar...
Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)
The emergence of immunotherapy has dramatically changed how NSCLC is treated and longer survival is now possible for some patients, even those with advanced disease. While some patients achieve durable responses to checkpoint blockade, not all experience such benefits, and some suffer from significa...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7372560/ https://ncbi.nlm.nih.gov/pubmed/31691957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32468 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|